A Study Investigating the Association of Dermatological and Infusion Reactions to Infliximab and Infliximab Trough Levels

BACKGROUND: Although infliximab is an effective therapy for inflammatory bowel disease (IBD), it is associated with dermatological events and infusion reactions. It is not known whether a relationship between these adverse events (AEs) and infliximab trough levels (ITLs) exists.

書目詳細資料

發表在:	Canadian Journal of Gastroenterology and Hepatology
Main Authors:	Vivian Wai-Mei Huang, Neil Dhami, Darryl Fedorak, Connie Prosser, Carol Shalapay, Karen Ivy Kroeker, Brendan Phillip Halloran, Levinus Albert Dieleman, Richard Neil Fedorak
格式:	Article
語言:	英语
出版:	Wiley 2015-01-01
在線閱讀:	http://dx.doi.org/10.1155/2015/428702